argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 696.00
-5.60 (-0.80%)
Feb 10, 2026, 12:54 PM CET
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
€1,963,265
Profits / Employee
€817,252
Market Cap
42.94B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 150 | 80.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UCB SA | 8,600 |
| European Medical Solutions | 123 |
| Onward Medical | 103 |
| Hyloris Pharmaceuticals | 50 |
| Celyad Oncology | 19 |
| Oxurion NV | 11 |
| BioSenic | 7 |
argenx SE News
- 11 days ago - Artisan Global Opportunities Fund Q4 2025 Portfolio Update - Seeking Alpha
- 19 days ago - Prime Capital Investment Advisors, LLC Buys 266 Shares of argenx SE (ARGX) - GuruFocus
- 19 days ago - Independence Bank of Kentucky Buys 2 Shares of argenx SE (ARGX) - GuruFocus
- 20 days ago - ARGX: Wells Fargo Raises Price Target to $1317, Maintains Overweight Rating | ARGX Stock News - GuruFocus
- 21 days ago - Artisan Mid Cap Fund Q4 2025 Performance Discussion And Portfolio Activity - Seeking Alpha
- 26 days ago - Wedbush Reiterates Outperform Rating for ARGX with $1000 PT | ARGX Stock News - GuruFocus
- 27 days ago - Argenx (ARGX) Gains FDA Priority Review for Expanded Vyvgart Use - GuruFocus
- 4 weeks ago - Argenx bid for Vyvgart label expansion undergoes FDA priority review - Seeking Alpha